143
Views
5
CrossRef citations to date
0
Altmetric
Editorial

Gut flora may offer new therapeutic targets for the traditional Chinese medicine enteric dialysis

, &
Pages 1147-1152 | Published online: 09 Sep 2011

Bibliography

  • Friedman EA. Can the bowel substitute for the kidney in advanced renal failure? Curr Med Res Opin 2009;25(8):1913-18
  • Schepers E, Glorieux G, Vanholder R. The gut: the forgotten organ in uremia? Blood Purif 2010;29(2):130-6
  • Sparks RE. Review of gastrointestinal perfusion in the treatment of uremia. Clin Nephrol 1979;11(2):81-5
  • Ranganathan N, Ranganathan P, Friedman EA, Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease. Adv Ther 2010;27(9):634-47
  • Yokozawa T, Suzuki N, Okuda I, Changes in the urinary constituents in rats with chronic renal failure during oral administration of rhubarb extract. Chem Pharm Bull (Tokyo) 1985;33(10):4508-14
  • Young TK, Lee SC, Tang CK. Diarrhea therapy of uremia. Clin Nephrol 1979;11(2):86-91
  • Young TK, Lee SC, Tai LN. Mannitol absorption and excretion in uremic patients regularly treated with gastrointestinal perfusion. Nephron 1980;25(3):112-16
  • Walker JB, Hannan JK. Creatine biosynthesis during embryonic development. False feedback suppression of liver amidinotransferase by N-acetimidoylsarcosine and 1-carboxymethyl-2-iminoimidazolidine (cyclocreatine). Biochemistry 1976;15(12):2519-22
  • Oi H, Matsuura D, Miyake M, Identification in traditional herbal medications and confirmation by synthesis of factors that inhibit cholera toxin-induced fluid accumulation. Proc Natl Acad Sci USA 2002;99(5):3042-6
  • Li LS, Liu ZH. Clinical and experimental studies of rheum on preventing progression of chronic renal failure. Zhongguo Zhong Xi Yi Jie He Za Zhi 1991;11(7):392-6
  • Zheng JM, Zhu JM, Li LS, Rhein reverses the diabetic phenotype of mesangial cells over-expressing the glucose transporter (GLUT1) by inhibiting the hexosamine pathway. Br J Pharmacol 2008;153(7):1456-64
  • Yang JW, Li LS. Effects of Rheum on renal hypertrophy and hyperfiltration of experimental diabetes in rat. Zhongguo Zhong Xi Yi Jie He Za Zhi 1993;13(5):286-8
  • Yokozawa T, Fujioka K, Oura H, Effects of rhubarb tannins on uremic toxins. Nephron 1991;58(2):155-60
  • Zhang G, el Nahas AM. The effect of rhubarb extract on experimental renal fibrosis. Nephrol Dial Transplant 1996;11(1):186-90
  • Jin YR, Jin J, Piao XX, The effect of Taraxacum officinale on gastric emptying and smooth muscle motility in Rodents. Neurogastroenterol Motil 2011;23(8):766-e333
  • Koh YJ, Cha DS, Ko JS, Anti-inflammatory effect of Taraxacum officinale leaves on lipopolysaccharide-induced inflammatory responses in RAW 264.7 cells. J Med Food 2010;13(4):870-8
  • Kim YH, Choo SJ, Ryoo IJ, Eudesmanolides from Taraxacum mongolicum and their inhibitory effects on the production of nitric oxide. Arch Pharmacol Res 2011;34(1):37-41
  • Whitman WB, Coleman DC, Wiebe WJ. Prokaryotes: the unseen majority. Proc Natl Acad Sci USA 1998;95(12):6578-83
  • Eckburg PB, Bik EM, Bernstein CN, Diversity of the human intestinal microbial flora. Science 2005;308(10):1635-8
  • McCartney AL. Application of molecular biological methods for studying probiotics and the gut flora. Br J Nutr 2002;88(Suppl 1):S29-37
  • Gill SR, Pop M, Deboy RT, Metagenomic analysis of the human distal gut microbiome. Science 2006;312(2):1355-9
  • Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003;361(5):512-19
  • Scanlan PD, Marchesi JR. Micro-eukaryotic diversity of the human distal gut microbiota: qualitative assessment using culture-dependent and -independent analysis of faeces. ISME J 2008;2(12):1183-93
  • Breitbart M, Rohwer F. Here a virus, there a virus, everywhere the same virus? Trends Microbiol 2005;13(6):278-84
  • Dethlefsen L, McFall-Ngai M, Relman DA. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 2007;449(10):811-18
  • Collins MD, Gibson GR. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr 1999;69(5):1052S-7S
  • Macfarlane GT, Macfarlane S. Models for intestinal fermentation: association between food components, delivery systems, bioavailability and functional interactions in the gut. Curr Opin Biotechnol 2007;18(2):156-62
  • Guarner F. Enteric flora in health and disease. Digestion 2006;73(Suppl 1):5-12
  • Jones JD, Burnett PC. Creatinine metabolism in humans with decreased renal function: creatinine deficit. Clin Chem 1974;20(9):1204-12
  • Mitch WE. Effects of intestinal flora on nitrogen metabolism in patients with chronic renal failure. Am J Clin Nutr 1978;31(9):1594-600
  • Simenhoff ML, Saukkonen JJ, Burke JF, Bacterial populations of the small intestine in uremia. Nephron 1978;22(1-3):63-8
  • Levanova LA, Aleshkin VA, Vorob'ev AA, Specific biological features of opportunistic bacteria determining dysbacteriosis in the composition of the large intestine normal microflora. Zh Mikrobiol Epidemiol Immunobiol 2002;Sep-Oct(5):48-53
  • Hida M, Aiba Y, Sawamura S, Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis. Nephron 1996;74(2):349-55
  • Gu KF, Chang TM. Conversion of ammonia or urea into essential amino acids, L-leucine, L-valine, and L-isoleucine, using artificial cells containing an immobilized multienzyme system and dextran-NAD+. 2. Yeast alcohol dehydrogenase for coenzyme recycling. Biotechnol Appl Biochem 1990;12(3):227-36
  • Chow KM, Liu ZC, Prakash S, Chang TM. Free and microencapsulated Lactobacillus and effects of metabolic induction on urea removal. Artif Cells Blood Substit Immobil Biotechnol 2003;31(4):425-34
  • O'Loughlin JA, Bruder JM, Lysaght MJ. Degradation of low molecular weight uremic solutes by oral delivery of encapsulated enzymes. Asaio J 2004;50(3):253-60
  • Prakash S, Chang TM. Artificial cells microencapsulated genetically engineered E. coli DH5 cells for the lowering of plasma creatinine in-vitro and in-vivo. Artif Cells Blood Substit Immobil Biotechnol 2000;28(5):397-408
  • Ranganathan N, Friedman EA, Tam P, Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada. Curr Med Res Opin 2009;25(8):1919-30
  • Ranganathan N, Patel BG, Ranganathan P, In vitro and in vivo assessment of intraintestinal bacteriotherapy in chronic kidney disease. Asaio J 2006;52(1):70-9
  • Turnbaugh PJ, Ley RE, Hamady M, The human microbiome project. Nature 2007;449(10):804-10
  • Ahmed N. A flood of microbial genomes-do we need more? PLoS One 2009;4(6):e5831
  • Eisen JA. Environmental shotgun sequencing: its potential and challenges for studying the hidden world of microbes. PLoS Biol 2007;5(3):e82
  • Hattori M, Taylor TD. The human intestinal microbiome: a new frontier of human biology. DNA Res 2009;16(1):1-12
  • Hattori M. Disease and metagenomics of intestinal microbiomes. Nippon Rinsho 2009;67(6):1214-18
  • Aziz RK. A hundred-year-old insight into the gut microbiome!. Gut Pathog 2009;1(1):21

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.